Mariner’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $106M | Buy |
1,744,281
+399,393
| +30% | +$23.3M | 0.12% | 144 |
|
|
2025
Q4 | $72.6M | Buy |
1,344,888
+441,112
| +49% | +$21.2M | 0.09% | 195 |
|
|
2025
Q3 | $40.8M | Buy |
903,776
+17,981
| +2% | +$840K | 0.05% | 279 |
|
|
2025
Q2 | $41M | Sell |
885,795
-33,621
| -4% | -$1.65M | 0.06% | 268 |
|
|
2025
Q1 | $56.1M | Buy |
919,416
+32,388
| +4% | +$1.89M | 0.09% | 196 |
|
|
2024
Q4 | $50.2M | Buy |
887,028
+19,292
| +2% | +$1.08M | 0.08% | 209 |
|
|
2024
Q3 | $44.9M | Sell |
867,736
-122,127
| -12% | -$5.73M | 0.08% | 221 |
|
|
2024
Q2 | $41.1M | Sell |
989,863
-408,329
| -29% | -$18.3M | 0.08% | 219 |
|
|
2024
Q1 | $75.8M | Sell |
1,398,192
-240,057
| -15% | -$12.2M | 0.16% | 129 |
|
|
2023
Q4 | $84.1M | Sell |
1,638,249
-44,678
| -3% | -$2.35M | 0.2% | 102 |
|
|
2023
Q3 | $97.7M | Sell |
1,682,927
-135,646
| -7% | -$8.31M | 0.26% | 82 |
|
|
2023
Q2 | $116M | Sell |
1,818,573
-155,340
| -8% | -$10.4M | 0.31% | 75 |
|
|
2023
Q1 | $137M | Buy |
1,973,913
+134,535
| +7% | +$9.49M | 0.4% | 56 |
|
|
2022
Q4 | $132M | Buy |
1,839,378
+314,314
| +21% | +$23.7M | 0.43% | 56 |
|
|
2022
Q3 | $108M | Sell |
1,525,064
-62,732
| -4% | -$4.55M | 0.43% | 55 |
|
|
2022
Q2 | $122M | Sell |
1,587,796
-69,232
| -4% | -$5.27M | 0.5% | 41 |
|
|
2022
Q1 | $121M | Sell |
1,657,028
-11,845
| -0.7% | -$795K | 0.46% | 48 |
|
|
2021
Q4 | $104M | Buy |
1,668,873
+845,304
| +103% | +$49.6M | 0.44% | 50 |
|
|
2021
Q3 | $48.7M | Buy |
823,569
+60,290
| +8% | +$3.97M | 0.25% | 102 |
|
|
2021
Q2 | $51M | Buy |
763,279
+18,906
| +3% | +$1.23M | 0.32% | 90 |
|
|
2021
Q1 | $47M | Sell |
744,373
-32,012
| -4% | -$1.99M | 0.33% | 90 |
|
|
2020
Q4 | $48.2M | Buy |
776,385
+76,474
| +11% | +$4.7M | 0.37% | 74 |
|
|
2020
Q3 | $42.2M | Buy |
699,911
+155,827
| +29% | +$9.38M | 0.4% | 65 |
|
|
2020
Q2 | $32M | Buy |
544,084
+399,127
| +275% | +$23.9M | 0.32% | 94 |
|
|
2020
Q1 | $8.08M | Buy |
144,957
+6,538
| +5% | +$400K | 0.1% | 190 |
|
|
2019
Q4 | $8.88M | Buy |
138,419
+44,040
| +47% | +$2.52M | 0.09% | 199 |
|
|
2019
Q3 | $4.79M | Sell |
94,379
-2,221
| -2% | -$104K | 0.06% | 242 |
|
|
2019
Q2 | $4.38M | Buy |
96,600
+13,409
| +16% | +$625K | 0.05% | 262 |
|
|
2019
Q1 | $3.97M | Buy |
83,191
+12,787
| +18% | +$637K | 0.06% | 269 |
|
|
2018
Q4 | $3.66M | Buy |
70,404
+26,453
| +60% | +$1.42M | 0.07% | 241 |
|
|
2018
Q3 | $2.73M | Sell |
43,951
-306
| -0.7% | -$18.2K | 0.07% | 246 |
|
|
2018
Q2 | $2.45M | Buy |
44,257
+7,237
| +20% | +$391K | 0.07% | 249 |
|
|
2018
Q1 | $2.34M | Sell |
37,020
-4,154
| -10% | -$267K | 0.08% | 205 |
|
|
2017
Q4 | $2.52M | Buy |
41,174
+1,176
| +3% | +$73.6K | 0.1% | 179 |
|
|
2017
Q3 | $2.55M | Sell |
39,998
-1,288
| -3% | -$75.2K | 0.12% | 150 |
|
|
2017
Q2 | $2.3M | Sell |
41,286
-41,728
| -50% | -$2.27M | 0.11% | 158 |
|
|
2017
Q1 | $4.51M | Buy |
83,014
+17,641
| +27% | +$968K | 0.2% | 101 |
|
|
2016
Q4 | $3.82M | Buy |
65,373
+5,015
| +8% | +$274K | 0.18% | 108 |
|
|
2016
Q3 | $3.25M | Buy |
60,358
+12,420
| +26% | +$798K | 0.16% | 121 |
|
|
2016
Q2 | $3.53M | Buy |
47,938
+15,297
| +47% | +$1.08M | 0.19% | 118 |
|
|
2016
Q1 | $2.08M | Buy |
32,641
+2,081
| +7% | +$131K | 0.12% | 158 |
|
|
2015
Q4 | $2.1M | Sell |
30,560
-9,594
| -24% | -$634K | 0.13% | 140 |
|
|
2015
Q3 | $2.38M | Sell |
40,154
-584
| -1% | -$37K | 0.11% | 163 |
|
|
2015
Q2 | $2.71M | Buy |
40,738
+23,970
| +143% | +$1.58M | 0.13% | 148 |
|
|
2015
Q1 | $1.08M | Sell |
16,768
-1,534
| -8% | -$96K | 0.09% | 174 |
|
|
2014
Q4 | $1.08M | Buy |
18,302
+9,407
| +106% | +$531K | 0.1% | 166 |
|
|
2014
Q3 | $455K | Sell |
8,895
-578
| -6% | -$28.9K | 0.05% | 224 |
|
|
2014
Q2 | $460K | Buy |
9,473
+1,953
| +26% | +$96.2K | 0.05% | 235 |
|
|
2014
Q1 | $391K | Sell |
7,520
-1,214
| -14% | -$64.6K | 0.05% | 227 |
|
|
2013
Q4 | $464K | Sell |
8,734
-2,201
| -20% | -$112K | 0.06% | 237 |
|
|
2013
Q3 | $506K | Sell |
10,935
-2,210
| -17% | -$97K | 0.09% | 188 |
|
|
2013
Q2 | $587K | Buy |
+13,145
| New | +$571K | 0.12% | 155 |
|
Other funds holding BMY
VCM
VPM
Mariner's BMY Position: Q1 2026 in Review
Mariner increased its Bristol-Myers Squibb (BMY) stake by 30% in Q1 2026, buying an estimated $23.3M and bringing the position to 1,744,281 shares worth $106M. The position accounts for 0.12% of the portfolio, ranked #144.
Mariner first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $137M in Q1 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Mariner held 1,744,281 shares of Bristol-Myers Squibb worth $106M as of Q1 2026.
- Mariner bought 399,393 Bristol-Myers Squibb shares in Q1 2026, an estimated $23.3M.
- Bristol-Myers Squibb made up 0.12% of Mariner's portfolio in Q1 2026, its #144 holding.
- Mariner first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Mariner's Bristol-Myers Squibb position peaked at $137M in Q1 2023.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.